STRATA Skin Sciences (SSKN) Cash & Current Investments (2010 - 2025)

STRATA Skin Sciences has disclosed Cash & Current Investments across 16 years of filings, most recently posting $7.9 million for Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $7.9 million, down 7.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.9 million (down 7.95% YoY), and the FY2025 annual result was $7.9 million, down 7.95% from the prior year.
• Cash & Current Investments came in at $7.9 million for Q4 2025 at STRATA Skin Sciences, up from $7.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $17.5 million in Q1 2021 to a low of $4.2 million in Q1 2023.
• The 5-year median for Cash & Current Investments is $8.4 million (2023), against an average of $9.4 million.
• Across the five-year window, Cash & Current Investments sank 61.68% in 2023 and jumped 56.98% in 2024, its largest moves.
• STRATA Skin Sciences' Cash & Current Investments stood at $12.6 million in 2021, then tumbled by 46.01% to $6.8 million in 2022, then climbed by 19.47% to $8.1 million in 2023, then advanced by 5.88% to $8.6 million in 2024, then dropped by 7.95% to $7.9 million in 2025.
• The last three Cash & Current Investments figures came in at $7.9 million (Q4 2025), $7.1 million (Q3 2025), and $6.0 million (Q2 2025), per Business Quant data.